Some investors may be asking whether CVS Health offers good value at around its recent price, or whether much of the potential upside in the stock has already been realized. Over the past year, CVS ...

CVS Health (CVS) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

CVS Health (CVS) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.

Shares of CVS Health (NYSE: CVS) have been declining recently as a potentially lower-than-expected increase in Medicare Advantage rates has investors worried about companies with exposure to health ...

CVS Health CVS is scheduled to report third-quarter 2025 results on Oct. 29, before the market opens. The Zacks Consensus Estimate for third-quarter earnings per share (EPS) suggests a 24.8% increase ...

CVS Health Corporation is rated a Buy with an 18% upside to a $97 price target, citing robust business momentum and undervaluation. CVS posted a strong FQ2 2025 double-beat, with revenue up 8.4% and ...

CVS Health (NYSE: CVS) will release its latest quarterly results and provide guidance updates pre-market on Tuesday, Feb. 10. Over the past four quarters, the healthcare giant has delivered earnings ...

Investors in CVS Health Corporation (Symbol: CVS) saw new options become available today, for the February 27th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the ...

The P/E ratio measures the current share price to the company's EPS. It is used by long-term investors to analyze the company's current performance against it's past earnings, historical data and ...